AG真人官方

QuantumScape Corporation (QS) 鈥� Form 4 insider activity

Chief Technology Officer Timothy Holme reported multiple transactions executed under a Rule 10b5-1 trading plan dated 13 Mar 2024.

• Share conversions: On 3 Jul 2025, 48,356 Class B shares held directly and 109,979 Class B shares held by The Holme 2020 Irrevocable Trust were converted 1-for-1 into Class A common stock.
• Option exercise: On 3 Jul 2025, Mr. Holme exercised options for 197,649 Class A shares at an exercise price of $1.3252 per share (grant 1 Apr 2017; expiry 15 Mar 2027).
• Open-market sales: 鈥� 3 Jul 2025 鈥� 358,330 direct shares and 98,073 trust shares sold at a weighted average price of $7.0252. 鈥� 7 Jul 2025 鈥� 43,500 direct shares and 11,906 trust shares sold at a weighted average price of $7.0178. Total shares sold: 511,809.
• Post-transaction holdings: 1,661,928 Class A shares held directly (including 1,437,698 RSUs/PSUs) and zero Class A shares held by the trust. Derivative holdings remain at 8,469,114 direct and 1,708,554 through the trust.

The transactions reduce Holme鈥檚 liquid equity exposure but leave him with a sizeable position and unvested equity incentives. No company-level financial metrics were included in this filing.

QuantumScape Corporation (QS) 鈥� Form 4 insider activity

Chief Technology Officer Timothy Holme reported multiple transactions executed under a Rule 10b5-1 trading plan dated 13 Mar 2024.

• Share conversions: On 3 Jul 2025, 48,356 Class B shares held directly and 109,979 Class B shares held by The Holme 2020 Irrevocable Trust were converted 1-for-1 into Class A common stock.
• Option exercise: On 3 Jul 2025, Mr. Holme exercised options for 197,649 Class A shares at an exercise price of $1.3252 per share (grant 1 Apr 2017; expiry 15 Mar 2027).
• Open-market sales: 鈥� 3 Jul 2025 鈥� 358,330 direct shares and 98,073 trust shares sold at a weighted average price of $7.0252. 鈥� 7 Jul 2025 鈥� 43,500 direct shares and 11,906 trust shares sold at a weighted average price of $7.0178. Total shares sold: 511,809.
• Post-transaction holdings: 1,661,928 Class A shares held directly (including 1,437,698 RSUs/PSUs) and zero Class A shares held by the trust. Derivative holdings remain at 8,469,114 direct and 1,708,554 through the trust.

The transactions reduce Holme鈥檚 liquid equity exposure but leave him with a sizeable position and unvested equity incentives. No company-level financial metrics were included in this filing.

Document type: PX14A6G (Notice of Exempt Solicitation). Bowyer Research, which owns less than $5 million of Albertsons Companies (ACI) stock, voluntarily files this notice to influence proxy voting.

Key request: Shareholders are urged to vote AGAINST Proposal 6, which asks the company to publish a report on the costs associated with differing state-level reproductive-health regulations.

• Core argument: The proposal drags Albertsons into an abortion debate unrelated to its business mission and could alienate customers, employees and investors, thereby eroding brand value.
• Faith-based critique: Bowyer notes that the lead proponent鈥攖he Presbyterian Church (USA) pension board鈥攁ppears to contradict traditional Christian views on the sanctity of life, potentially confusing faith-driven stakeholders.
• Demographic angle: Wider abortion access may reduce future population growth, ultimately shrinking the grocer鈥檚 long-term customer base.
• Operational impact: Albertsons already offers legally compliant, comprehensive health benefits; extra reporting would divert resources and expose the company to unnecessary reputational and political risk.

Call to action: Vote NO on Proposal 6. Bowyer Research bears all solicitation costs and is not asking for proxy cards.

QuantumScape Corp. (QS) 鈥� Form 144/A filing discloses a planned sale of 1,302,600 Class A common shares through Goldman Sachs & Co. LLC on or about 3 July 2025. The amount equals roughly 0.25 % of the company鈥檚 515.7 million shares outstanding. Aggregate market value of the proposed sale is listed at $9.14 million.

The shares were primarily acquired via long-term equity compensation and option exercises between 2011-2023, plus conversion of earlier Class B shares. No sales have been made by the filer in the past three months, and the filer attests to not possessing undisclosed material adverse information. No earnings or balance-sheet data accompany the notice; the filing is strictly a regulatory disclosure of an intended insider disposition under Rule 144.

QuantumScape Corporation (QS) 鈥� Form 144 filing dated 07/03/2025. The notice discloses a proposed sale of 864,708 Class A common shares through Goldman Sachs & Co. with an aggregate market value of $6.07 million. The shares equal roughly 0.17% of the company鈥檚 515.7 million shares outstanding and are expected to be sold on or after 07/03/2025 on the NYSE.

Source of shares. 鈥� 508,832 shares were originally Class B stock acquired privately from the issuer on 09/02/2020 and will convert to Class A upon sale. 鈥� Two additional blocks of 177,938 shares each were received as gifts on 10/08/2021 from the Friedrich Prinz & Gertrud Prinz Annuity Trusts.

Recent activity. The filer previously sold 61,523 Class A shares on 05/22/2025, generating gross proceeds of $240,997.90.

Key context. Form 144 is a notice, not a commitment; sales may or may not occur. No adverse inside information is asserted, and the filer certifies compliance with Rule 144 and, if applicable, Rule 10b5-1.

QuantumScape Corporation (QS) filed a Form 144 indicating that an unidentified insider intends to sell up to 1,302,600 Class A common shares through Goldman Sachs & Co. on or around 3 July 2025. At the company鈥檚 reported outstanding share count of 515,685,016, the proposed sale represents roughly 0.25 % of shares outstanding. The filing assigns an aggregate market value of US$9.14 million, implying an indicative price of about US$7.02 per share鈥攇enerally consistent with recent trading ranges.

The shares were accumulated primarily via option exercises and performance-based compensation between 2017 and 2023, plus a sizable 2011 private acquisition of Class B stock now convertible to Class A. The filer reports no sales during the past three months. While Form 144 merely signals intent and not certainty of execution, it alerts the market to potential supply.

Investor Takeaway: A sale of this size is modest relative to total float and is unlikely to create meaningful dilution, yet insider selling can be viewed as a bearish sentiment indicator. The absence of recent sales and the structured use of a major broker suggest an orderly disposition rather than an urgent liquidation.

QuantumScape (NYSE:QS) filed a Form 4 on 27 June 2025 detailing Chief Development Officer Mohit Singh鈥檚 option exercises and corresponding share sales executed under a Rule 10b5-1 plan adopted 12 Sept 2024.

• Options exercised: 615,000 shares at strike prices of $1.3252 and $2.377.
• Shares sold: 615,000 Class A shares for a weighted-average consideration of roughly $4.1 million (prices ranged $5.69鈥�$7.245).
• Post-transaction ownership: 1,641,711 shares, including 1,437,698 unvested RSUs/PSUs鈥攗nchanged versus pre-transaction level.
• No open-market purchases occurred; activity appears designed to generate liquidity while keeping the equity stake constant.

No other material company developments were disclosed.

QuantumScape Corp (NYSE: QS) Officer Mohit Singh has filed Form 144 indicating intent to sell 325,000 shares of common stock with an aggregate market value of $2,343,607.50. The sale is planned through Fidelity Brokerage Services LLC with an approximate sale date of June 26, 2025.

The securities were acquired through stock options on June 26, 2025. Notable recent trading activity by Singh includes:

• May 19, 2025: Sold 71,428 shares for $315,318.91
• June 25, 2025: Sold 290,000 shares for $1,727,675.00

The filing indicates Singh is operating under a Rule 10b5-1 trading plan adopted on September 12, 2024. As of the filing date, QuantumScape has 515,685,016 shares outstanding. The seller affirms no knowledge of undisclosed material adverse information regarding the company's operations.

QuantumScape insider Mohit Singh has filed Form 144 declaring intention to sell 290,000 shares of common stock with an aggregate market value of $1,727,675. The proposed sale is planned for June 25, 2025, through Fidelity Brokerage Services on the NYSE.

The securities were acquired through stock options on June 25, 2025. The filing reveals previous insider sales by Singh in the past 3 months:

• May 19, 2025: 71,428 shares for $315,318.91
• February 21, 2025: 22,747 shares for $121,505.37
• February 20, 2025: 30,957 shares for $159,010.63

The company currently has 515,685,016 shares outstanding. This Form 144 represents Singh's declaration of intention to sell approximately 0.06% of total shares outstanding, indicating a relatively minor impact on the company's float.